• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期接受氟比洛芬治疗的类风湿患者的血清氟比洛芬浓度。

Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time.

作者信息

Cardoe N, de-Silva M, Glass R C, Risdall P C

出版信息

Curr Med Res Opin. 1977;5(1):21-5. doi: 10.1185/03007997709108971.

DOI:10.1185/03007997709108971
PMID:913119
Abstract

Serum concentrations of flurbiprofen were measured following single oral doses of 50 mg to 200 mg in patients who previously had received flurbiprofen over long periods of time. The apparent elimination half-lives in groups of patients who received different doses were not significantly different from each other nor from the value previously obtained in a group of healthy volunteers given a single oral dose of 50 mg. Areas under serum concentration versus time curves were linearly related to dose over the range of doses examined. The results indicate that the pharmacokinetics of flurbiprofen are not significantly dose-dependent over the range of doses studied and that administration of relatively high doses of flurbiprofen over long periods of time neither induces nor inhibits flurbiprofen metabolism.

摘要

在长期服用氟比洛芬的患者中,单次口服50毫克至200毫克剂量后测量血清氟比洛芬浓度。接受不同剂量的患者组的表观消除半衰期彼此之间无显著差异,也与先前给予单次口服50毫克剂量的一组健康志愿者所获得的值无显著差异。在所研究的剂量范围内,血清浓度-时间曲线下面积与剂量呈线性相关。结果表明,在所研究的剂量范围内,氟比洛芬的药代动力学无显著剂量依赖性,并且长期给予相对高剂量的氟比洛芬既不诱导也不抑制氟比洛芬代谢。

相似文献

1
Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time.长期接受氟比洛芬治疗的类风湿患者的血清氟比洛芬浓度。
Curr Med Res Opin. 1977;5(1):21-5. doi: 10.1185/03007997709108971.
2
Flurbiprofen at night.夜间服用氟比洛芬。
Curr Med Res Opin. 1977;5(1):85-7. doi: 10.1185/03007997709108982.
3
The optimum interval between flurbiprofen doses--scheduling for circadian rhythms in rheumatoid arthritis.氟比洛芬剂量之间的最佳间隔——类风湿关节炎昼夜节律的给药方案安排
Br J Clin Pract. 1987 Apr;41(4):689-93.
4
Flurbiprofen-aspirin interaction: a double-blind crossover study.氟比洛芬-阿司匹林相互作用:一项双盲交叉研究。
Curr Med Res Opin. 1977;5(1):53-7. doi: 10.1185/03007997709108977.
5
Comparison of two dosing schedules of flurbiprofen for patients with rheumatoid arthritis. Twice-daily versus four-times-a-day schedules.类风湿关节炎患者使用氟比洛芬两种给药方案的比较。每日两次与每日四次给药方案。
Am J Med. 1986 Mar 24;80(3A):19-22. doi: 10.1016/0002-9343(86)90106-3.
6
Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.类风湿关节炎的体征和症状的昼夜变化以及氟比洛芬在一天中不同时间的治疗效果。
Br J Clin Pharmacol. 1981 May;11(5):477-84. doi: 10.1111/j.1365-2125.1981.tb01153.x.
7
The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.氟比洛芬对映体在类风湿性关节炎患者中的药代动力学。
Br J Clin Pharmacol. 1991 Jan;31(1):102-4. doi: 10.1111/j.1365-2125.1991.tb03865.x.
8
A comparative analysis of two dosing strategies of flurbiprofen in rheumatoid arthritis: an application of sequential trial design.
Clin Invest Med. 1988 Dec;11(6):441-5.
9
Pharmacokinetics of flurbiprofen.
Am J Med. 1986 Mar 24;80(3A):10-5. doi: 10.1016/0002-9343(86)90104-x.
10
Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.活动性类风湿疾病患者血清和滑液中氟比洛芬的浓度:一些初步观察结果。
Curr Med Res Opin. 1977;5(1):17-20. doi: 10.1185/03007997709108970.

引用本文的文献

1
Flurbiprofen-loaded stealth liposomes: studies on the development, characterization, pharmacokinetics, and biodistribution.载有氟比洛芬的隐形脂质体:关于其开发、表征、药代动力学和生物分布的研究
J Young Pharm. 2012 Oct;4(4):209-19. doi: 10.4103/0975-1483.104364.
2
Flurbiprofen concentration in soft tissues is higher after topical application than after oral administration.局部应用后,软组织结构中的氟比洛芬浓度高于口服后。
Br J Clin Pharmacol. 2013 Mar;75(3):799-804. doi: 10.1111/j.1365-2125.2012.04394.x.
3
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.
非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
4
Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.氟比洛芬在类风湿性关节炎中的血浆及滑液动力学
Br J Clin Pharmacol. 1986 Feb;21(2):155-63. doi: 10.1111/j.1365-2125.1986.tb05170.x.
5
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.氟比洛芬:其药理学特性及在风湿性疾病中的治疗应用综述
Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001.